Severity
Moderate
FDA Drug recall · Reported March 12, 2025
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Safecor Health, LLC recalled Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral Syringe, Deli… - a moderate-severity action.
Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral Syringe, Deli… was recalled by Safecor Health, LLC in March 12, 2025. Reason: Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.. Check the official notice for the remedy. Verify recall #D-0250-2025 with the FDA Drug before acting.
The recall
Safecor Health, LLC issued this moderate-severity FDA Drug recall-Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes..
Sourced from official FDA Drug enforcement records. Verify recall #D-0250-2025 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0250-2025) was formally reported on March 12, 2025, with the manufacturer initiating the action on February 17, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. Safecor Health, LLC is listed as the recalling firm, operating out of Columbus, OH. Federal records list the affected scope as 3069 Oral Syringes.
The documented reason for this recall is: Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes. Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug and 1 from Safecor Health, LLC - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
3069 Oral Syringes
Related Recalls
6
5 from same agency
Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral Syringe, Delivers: 0.05 mL Oral Solution, Mfg by: Westminster, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: 69367028302.
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0250-2025 |
| Date reported | March 12, 2025 |
| Date initiated | February 17, 2025 |
| Recalling firm | Safecor Health, LLC |
| Firm location | Columbus, OH |
| Affected scope | 3069 Oral Syringes |
| Distribution | Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported March 12, 2025. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.